News
10-06-2011, 02:06 AM
Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA's Jonsson Comprehensive Cancer Center reported Wednesday...
More... (http://www.medicalnewstoday.com/releases/235543.php)
More... (http://www.medicalnewstoday.com/releases/235543.php)